LAL-D: A Life-Threatening Genetic Disease with Progressive, Multiorgan Damage Leading To Premature Death
1

Lysosomal Acid Lipase Deficiency (LAL-D), historically known as Wolman disease and cholesteryl ester storage disease (CESD), may lead to severe systemic consequences including fibrosis, cirrhosis, cardiovascular complications, and malabsorption.1,2

LAL-D patients are deficient in the vital LAL enzyme, resulting in significant morbidities and may lead to premature death1

~50%

Percentage of patients who progressed to fibrosis, cirrhosis, or liver transplant within 3 years of first clinical manifestation.3

Resources

diagnostic information
For help diagnosing patients...

Information to help uncover LAL-D patients who might be hiding in your practice.

To participate in research...

Global registry dedicated to helping physicians improve management of LAL-D.

REGISTER TODAY

and receive all the latest LAL-D information.

*All fields are required

THANK YOU
Your registration on LALDSource.com ensures that you will be among the first to receive news and updates about LAL-D.